Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Badir Delf Loveymi

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advanced Pharmaceutical Bulletin|December 7, 2013
Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeabilityBadir Delf Loveymi, Mitra Jelvehgari, Parvin Zakeri-Milani, et al.
Colloids and Surfaces. B, Biointerfaces|December 4, 2012
The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery systemParvin Zakeri-Milani, Badir Delf Loveymi, Mitra Jelvehgari, et al.
Iranian Journal of Pharmaceutical Research : IJPR|November 20, 2013
Statistical Optimization of Oral Vancomycin-Eudragit RS Nanoparticles Using Response Surface MethodologyBadir Delf Loveymi, Mitra Jelvehgari, Parvin Zakeri-Milani, et al.
AAPS Pharmscitech|August 6, 2010
Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weightsMitra Jelvehgari, Parvin Zakeri-Milani, Mohammad Reza Siahi-Shadbad, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advanced Pharmaceutical Bulletin|December 7, 2013
Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeabilityBadir Delf Loveymi, Mitra Jelvehgari, Parvin Zakeri-Milani, et al.
Colloids and Surfaces. B, Biointerfaces|December 4, 2012
The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery systemParvin Zakeri-Milani, Badir Delf Loveymi, Mitra Jelvehgari, et al.
Iranian Journal of Pharmaceutical Research : IJPR|November 20, 2013
Statistical Optimization of Oral Vancomycin-Eudragit RS Nanoparticles Using Response Surface MethodologyBadir Delf Loveymi, Mitra Jelvehgari, Parvin Zakeri-Milani, et al.
AAPS Pharmscitech|August 6, 2010
Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weightsMitra Jelvehgari, Parvin Zakeri-Milani, Mohammad Reza Siahi-Shadbad, et al.
Pageof 1